• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥氮平所致不安腿综合征。

Olanzapine-induced restless legs syndrome.

作者信息

Zhao Mangsuo, Geng Tongchao, Qiao Liyan, Zhang Mingjie, Shi Jie, Huang Fangjie, Lin Xianzhong, Wang Jing, Zuo Huancong

机构信息

Department of Neurology, Yuquan Hospital, Medical Center, Tsinghua University, Beijing, PR China.

School of Medicine, Nankai University, Tianjin, PR China.

出版信息

J Clin Neurosci. 2014 Sep;21(9):1622-5. doi: 10.1016/j.jocn.2014.01.007. Epub 2014 May 27.

DOI:10.1016/j.jocn.2014.01.007
PMID:24874697
Abstract

Only nine patients with olanzapine-induced restless legs syndrome (RLS) have been reported in the literature to our knowledge. We describe two patients with olanzapine-induced RLS treated at our hospital and review the nine reported patients. There were five women and six men aged between 28 and 62 years in the overall group. RLS symptoms emerged at olanzapine doses between 2.5 and 20mg. The symptoms improved in all patients when the dose was reduced and immediately disappeared when the medication was stopped. International Restless Legs Scale (IRLS) scores ranged from 10 to 35. Three patients had a family history of idiopathic RLS. Supplemental drugs were administered to control RLS symptoms in five patients. Ropinirole was effective in one patient, while two patients did not respond to the drug. Propoxyphene effectively relieved symptoms in one patient who did not respond to ropinirole or clonazepam. RLS symptoms did not recur following substitution of other antipsychotic drugs for olanzapine. In conclusion, olanzapine can induce RLS, particularly in patients with a family history of idiopathic RLS. More than half of the patients experienced severe to very severe symptoms. A dose-dependent relationship was observed between olanzapine and RLS symptoms. A gradual increase in dose may prevent olanzapine-induced RLS. The optimal treatment for olanzapine-induced RLS is discontinuation of olanzapine.

摘要

据我们所知,文献中仅报道了9例奥氮平所致的不宁腿综合征(RLS)患者。我们描述了在我院接受治疗的2例奥氮平所致RLS患者,并对报道的9例患者进行了回顾。总共有5名女性和6名男性,年龄在28至62岁之间。RLS症状出现在奥氮平剂量为2.5至20mg之间时。当剂量减少时,所有患者的症状均有所改善,停药后症状立即消失。国际不宁腿量表(IRLS)评分在10至35分之间。3例患者有特发性RLS家族史。5例患者使用了补充药物来控制RLS症状。罗匹尼罗对1例患者有效,而2例患者对该药物无反应。丙氧芬有效地缓解了1例对罗匹尼罗或氯硝西泮无反应患者的症状。用其他抗精神病药物替代奥氮平后,RLS症状未复发。总之,奥氮平可诱发RLS,尤其是有特发性RLS家族史的患者。超过一半的患者经历了严重至极严重的症状。奥氮平和RLS症状之间存在剂量依赖关系。逐渐增加剂量可能预防奥氮平所致的RLS。奥氮平所致RLS的最佳治疗方法是停用奥氮平。

相似文献

1
Olanzapine-induced restless legs syndrome.奥氮平所致不安腿综合征。
J Clin Neurosci. 2014 Sep;21(9):1622-5. doi: 10.1016/j.jocn.2014.01.007. Epub 2014 May 27.
2
Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine.
J Psychopharmacol. 2009 Jul;23(5):597-601. doi: 10.1177/0269881108091876. Epub 2008 Jun 18.
3
Refractory restless legs syndrome likely caused by olanzapine.难治性不宁腿综合征可能由奥氮平引起。
J Clin Sleep Med. 2009 Feb 15;5(1):68-9.
4
Olanzapine-induced restless leg syndrome: a case report and review of literature.奥氮平诱发的不宁腿综合征:一例病例报告及文献综述
Indian J Pharmacol. 2014 Jul-Aug;46(4):450-2. doi: 10.4103/0253-7613.135965.
5
Restless leg syndrome associated with olanzapine: a case series.奥氮平相关的不宁腿综合征:病例系列
Curr Drug Saf. 2010 Apr;5(2):129-31. doi: 10.2174/157488610790936187.
6
[Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication].[肾功能不全透析患者的不宁腿综合征:药物治疗效果]
Dtsch Med Wochenschr. 2008 Jan;133(3):71-5. doi: 10.1055/s-2008-1017476.
7
Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.罗匹尼罗治疗基线 IRLS 总分≥24 的不安腿综合征患者:26 周双盲、平行分组、安慰剂对照研究及随后 40 周开放性扩展研究的疗效和耐受性。
Clin Ther. 2013 Sep;35(9):1321-36. doi: 10.1016/j.clinthera.2013.06.016. Epub 2013 Aug 9.
8
Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.帕金森病患者不安腿综合征的临床特征
J Neurol Sci. 2006 Dec 1;250(1-2):39-44. doi: 10.1016/j.jns.2006.06.023. Epub 2006 Aug 8.
9
Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.不宁腿综合征多巴胺能增强的诊断标准:马克斯·普朗克研究所世界睡眠医学协会-国际不宁腿综合征研究小组共识会议报告
Sleep Med. 2007 Aug;8(5):520-30. doi: 10.1016/j.sleep.2007.03.022. Epub 2007 Jun 1.
10
Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.罗匹尼罗治疗不宁腿综合征的临床疗效不受症状起始年龄的影响。
Sleep Med. 2008 Dec;9(8):899-902. doi: 10.1016/j.sleep.2007.08.017. Epub 2007 Nov 19.

引用本文的文献

1
Exploring the Top 50 Drugs Associated with Restless Legs Syndrome Based on the FDA Data from 2004 to 2024.基于美国食品药品监督管理局2004年至2024年的数据探索与不宁腿综合征相关的前50种药物。
Nat Sci Sleep. 2025 May 15;17:929-946. doi: 10.2147/NSS.S513538. eCollection 2025.
2
Restless Back Syndrome: A Case Report and Literature Review.不安背综合征:一例报告及文献综述
Psychiatry Clin Psychopharmacol. 2022 Dec 1;32(4):351-354. doi: 10.5152/pcp.2022.22441. eCollection 2022 Dec.
3
Restless arms syndrome with oral olanzapine: case based review.
口服奥氮平所致不安手臂综合征:基于病例的综述
Heliyon. 2022 Dec 15;8(12):e12258. doi: 10.1016/j.heliyon.2022.e12258. eCollection 2022 Dec.
4
Management Dilemma in Olanzapine Induced Restlessness and Cramps in Legs.奥氮平所致不安和腿部痉挛的管理困境
Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):87-88. doi: 10.9758/cpn.2017.15.1.87.
5
Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature.加巴喷丁治疗氯氮平所致不安腿综合征:两例报告及文献复习
Ther Adv Psychopharmacol. 2017 Jan;7(1):42-47. doi: 10.1177/2045125316672133. Epub 2016 Oct 12.